Introduction {#s1}
============

*Clostridium perfringens* is a Gram-positive spore-forming anaerobe, best known as the causative agent for the tissue necrotic disease gas gangrene (also known as Clostridial myonecrosis). Notably, *C. perfringens* has also been widely associated with various intestinal diseases across human and animal species including: broiler necrotic enteritis (Keyburn et al., [@B37]), human food poisoning (Scallan et al., [@B80]), and preterm necrotising enterocolitis (Sim et al., [@B84]; Heida et al., [@B30]). Remarkably, it is reported to secrete \>20 degradative toxins which constitute its primary arsenal to initiate histotoxic pathogenesis in both humans and animals (Uzal et al., [@B91]; Revitt-Mills et al., [@B73]). Intestinal-associated disease aetiology is characterised by rapid anaerobic proliferation in host tissue accompanied by *in vivo* production of several key pore-forming toxins including α-toxin, β-toxin, and β2-toxin, that consequently disrupt epithelial barrier function and induce histotoxic infections or tissue necrosis (Li and Mcclane, [@B46]). Common disease symptoms include pronounced diarrhoea (human adult food poisoning) (Mcclung, [@B50]), gaseous tissue necrosis (neonatal humans and animals) (Kosloske et al., [@B40]), and a haemorrhagic gut (neonatal horses) (Mehdizadeh Gohari et al., [@B52]).

*C. perfringens* was first isolated in the 1890s and named *Clostridium welchii* after its discoverer William Henry Welch (Welch and Nuttall, [@B95]). This gut pathogen is serotyped (or, specifically toxinotyped) clinically from A to E based upon the combination of "major toxins" (namely, α-toxin, β-toxin, ι-toxin, and ε-toxin) it encodes (Hassan et al., [@B29]). Multiplex PCR on the key toxin genes and Matrix Assisted Laser Desorption/Ionization time-of-flight mass (MALDI-TOF) spectrometry are the most common typing/identification methods in medical laboratories alongside conventional culture-based biochemical identification (Van Asten et al., [@B92]; Nagy et al., [@B60]).

Although this widespread gut pathogen has been studied and experimentally characterised over the past century, these studies have primarily focused on *C. perfringens*-associated toxins (Nagler, [@B58]; Ohno-Iwashita et al., [@B63]; Gibert et al., [@B23]; Stevens and Bryant, [@B85]). Notably, information on the entire pangenome \[or, "the entire collection of gene families that are found in a given species" (Mcinerney et al., [@B51])\] of this pathogen is limited; to the date of analysis (April 2017) only 51 strains have been sequenced and made available publicly (Geer et al., [@B22]).

Previous comparative genomic studies on *C. perfringens* (up to 12 strains) indicated substantial genome variation within the pangenome (Hassan et al., [@B29]). Hence, we sought to construct the latest and largest pangenome of *C. perfringens* to probe evolutionary relationships and understand the genomic makeup of this bacterium. The *C. perfringens* genomes publicly available represent strains isolated from various diseased hosts including gas gangrene (human), food poisoning (human), necrotic enteritis (poultry), enterotoxaemia (sheep), and haemorrhagic enteritis (dogs and foals) from the past 100 years. This collection also represents the full range of *C. perfringens* toxinotypes (A--E). In this study, we also sequenced an additional 5 *C. perfringens* strains (as part of the NCTC3000 project[^1^](#fn0001){ref-type="fn"}), for their historical significance (mostly isolated before 1960s), and thus included 56 genomes (including 51 genomes in NCBI databases) in our *in silico* investigation. Here we characterise genomic aspects of this medically and veterinary important pathogen, and through bioinformatic analysis of Whole Genome Sequencing (WGS) data identify virulence traits, define evolutionary relationships and functional annotations of the pangenome. Our analysis indicates that *C. perfringens* has a surprisingly diverse pangenome (core genes \~12.6%), potentially driven by horizontal gene transfer (HGT).

Results {#s2}
=======

Probing evolutionary relationships
----------------------------------

Initially we sought to determine taxonomy and phylogenetic relatedness between *C. perfringens* and a subset of pathogenic/environmental *Clostridium* species (25) using 16S rRNA approach (Supplementary Table [1](#SM2){ref-type="supplementary-material"}) (Woese et al., [@B96]) as previous earlier studies had reported that *Clostridium pasteurianum, Clostridium baratii*, and *Clostridium absonum* were the closest relatives (Canard et al., [@B13]; Collins et al., [@B15]). Using the 16S rRNA gene predictor Barrnap (\>800 bp sequences used, 38/56 strains) we determined that the 16S rRNA regions appear to be highly conserved (identity \>99.1%; Supplementary Table [2](#SM1){ref-type="supplementary-material"}) across all selected 38 *C. perfringens* strains as they form a monophyletic lineage in the 16S *Clostridium* phylogenetic tree. *C. perfringens* cluster was clearly separated from other *Clostridium* species, with closest relatives identified as *C. baratii* (toxin producer associated with infant botulism) and *Clostridium sardiniense* (α-toxin producers isolated from gas gangrene cases) (Figure [1](#F1){ref-type="fig"}) (Masaki et al., [@B49]; Harvey et al., [@B28]). Clinically important toxin-generating bacteria *C. botulinum*, potentially pathogenic *Clostridium paraputrificum, Clostridium tertium*, scavenger *Clostridium cadaveris*, and deadly-toxin producer *Clostridium tetani* all fall in the same sub-lineage (cluster 2) as *C. perfringens*, with *Clostridium difficile* (known for nosocomial antibiotic-associated diarrhea), *Clostridium sordellii* and *C. bifermentans* (uncommon environmental species infrequently linked to human diseases) diverging earlier from their common ancestor (cluster 1), suggesting an ancient divergence in evolutionary history (Edagiz et al., [@B17]).

![16S rRNA phylogeny of representative *Clostridium* species (25) and *C. perfringens*. **(A)** Maximum-likelihood phylogenetic tree of *C. perfringens* strains and representative *Clostridium* species (25) based on 16S rRNA genes with aLRT branch support values displayed. **(B)** Neighbour-joining phylogeny based on 16S rRNA genes supported by 1000 bootstrap replicates based on 1585 sites. Clusters 1 and 2 were assigned for description purposes. Branch support values \>70 are shown on the nodes.](fmicb-08-02485-g0001){#F1}

Evolutionary distances based on near full-length 16S rRNA gene sequence (Table [1](#T1){ref-type="table"}) also indicates that *C. baratii* and *C. sardiniense* are the closest relatives of *C. perfringens* in this dataset with sequence identities of \~95%, followed by *C. absonum* (94%), *C. paraputrificum* (93%), *C. septicum* (93%), *C. butyricum* (93%), *C. tetani* (91%), and *C. pasteurianum* (90%). These data support the 16S rRNA ML tree (Figure [1](#F1){ref-type="fig"}) as strains with higher sequence identities all appear to be more closely related to *C. perfringens* as indicated by tree topology.

###### 

16S rRNA sequence pair-wise comparison between five representative *C. perfringens* strains and 20 selected *Clostridium* species.

  **Strains**                            ***Clostridium perfringens***                                                                   
  -------------------------------------- ------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- -------
  *Clostridium baratii* JCM1385          95.33                           100     95.06   100     95.33   100     95.26   100     95.33   100
  *Clostridium sardiniense* DSM2632      95.18                           99.67   94.92   99.80   95.05   99.67   95.11   99.67   95.18   99.67
  *Clostridium absonum* DSM599           94.35                           99.79   94.08   99.93   94.21   99.79   94.16   100     94.35   99.79
  *Clostridium paraputrificum* DSM2630   93.77                           99.93   93.52   100     93.77   99.93   93.91   100     93.64   99.93
  *Clostridium sartagoforme* KAR69       93.73                           99.86   93.60   100     93.66   99.86   93.73   99.86   93.59   99.86
  *Clostridium septicum* JCM8147         93.70                           100     93.57   100     93.77   100     93.63   100     93.56   100
  *Clostridium isatidis* MV1             93.58                           99.93   93.32   100     93.71   99.93   93.91   99.93   93.44   99.93
  *Clostridium fallax* JCM1398           93.57                           100     93.45   100     93.50   100     93.52   100     93.44   100
  *Clostridium tertium* ATCC14573        93.53                           100     93.25   100     93.46   100     93.53   100     93.38   100
  *Clostridium botulinum* E133           93.45                           100     91.09   100     93.52   100     93.67   100     93.59   100
  *Clostridium butyricum* JCM1391        93.42                           100     93.30   100     93.49   100     93.63   100     93.29   100
  *Clostridium botulinum* Eklund17B      93.32                           100     93.10   100     93.32   100     93.48   100     93.47   100
  *Clostridium celatum* JCM1394          92.82                           100     92.56   100     92.89   100     92.82   100     92.69   100
  *Clostridium carnis* ATCC25777         92.57                           99.86   92.30   100     92.50   99.86   92.57   99.86   92.43   99.86
  *Clostridium cellulovorans* 743B       91.64                           100     91.39   100     91.71   100     91.91   100     91.51   100
  *Clostridium tetani* HT1               91.21                           99.93   91.09   100     91.14   99.93   91.35   100     91.35   99.93
  *Clostridium cadaveris* JCM1392        90.58                           100     90.32   100     90.58   100     90.79   100     90.51   100
  *Clostridium pasteurianum* JCM1408     90.22                           100     90.10   100     90.29   100     90.28   100     90.09   100
  *Clostridium difficile* JCM5248        86.25                           100     86.14   100     86.32   100     86.39   100     86.25   100
  *Clostridium bifermentans* JCM1386     85.82                           100     85.68   100     85.89   100     85.89   100     85.82   100
  *Clostridium rectum* NCIMB10651        79.66                           100     79.60   100     79.66   100     79.63   100     79.57   100

Genome description
------------------

A total of 51 genomes were retrieved in preassembled nucleotide FASTA files from NCBI database for further analysis (March 2017) and 5 NCTC strains were subjected to optimised DNA extraction procedures and sequenced (PacBio) as part of NCTC 3000 project ([www.sanger.ac.uk/resources/downloads/bacteria/nctc/](http://www.sanger.ac.uk/resources/downloads/bacteria/nctc/)) with genomes annotated using Prokka. Whilst, contig number was variable (1--274) for NCBI-associated genomes (sequenced by different platforms and assembled using different methods), NCTC13170 and NCTC2544 reads assembled into 1 unitig, and NCTC8503, NCTC8797, and NCTC8678 genomes \<10 contigs. Genome size of *C. perfringens* isolates ranged from 2.9 to 4.1 million bases, with an average GC content between 27.7 and 28.7% (Table [2](#T2){ref-type="table"}). Predicted genes range from 2,600 to 3,800 with a median of 3304 genes.

###### 

Genome description of 56 *C. perfringens* isolates included in this study.

                           **Strain**           **Genome size (bp)**   **Contigs**       **Predicted genes**   **G+C (%)**
  ------------------------ -------------------- ---------------------- ----------------- --------------------- -------------
  1                        1207                 3207161                95                2838                  28.11
  2                        13                   3085740                2                 2827                  28.51
  3                        2789STDY5608889      3321076                48                3000                  28.08
  4                        ATCC13124            3256683                1                 2973                  28.38
  5                        B_ATCC3626           3896305                98                3563                  28.36
  6                        C_JGS1495            3661329                84                3354                  28.58
  7                        CP4                  3642209                98                3469                  27.80
  8                        CPE_F4969            3510272                74                3172                  28.57
  9                        D_JGS1721            4045016                221               3768                  28.26
  10                       E_JGS1987            4127102                101               3896                  28.08
  11                       F262                 3464306                53                3213                  28.00
  12                       FORC003              3395109                2                 3091                  28.41
  13                       FORC025              3343822                1                 3082                  28.49
  14                       JFP718               3652220                56                3387                  27.99
  15                       JFP727               3624033                47                3355                  28.01
  16                       JFP728               3579626                85                3313                  27.98
  17                       JFP771               3495308                81                3245                  27.99
  18                       JFP774               3548595                56                3252                  28.03
  19                       JFP795               3578912                67                3286                  28.01
  20                       JFP796               3601148                114               3330                  28.01
  21                       JFP801               3580610                59                3298                  28.01
  22                       JFP804               3625968                117               3331                  28.02
  23                       JFP810               3830406                95                3651                  28.04
  24                       JFP826               3660408                70                3398                  27.99
  25                       JFP828               3564370                54                3303                  27.99
  26                       JFP829               3639686                108               3354                  27.96
  27                       JFP833               3521770                96                3277                  27.94
  28                       JFP834               3549140                121               3305                  27.88
  29                       JFP836               3599532                51                3341                  28.03
  30                       JFP914               3819232                79                3607                  27.96
  31                       JFP916               3660641                67                3400                  28.02
  32                       JFP921               3601767                78                3310                  27.95
  33                       JFP922               3612099                76                3334                  27.98
  34                       JFP923               3589715                48                3291                  28.02
  35                       JFP941               3594640                64                3330                  28.00
  36                       JFP961               3617219                66                3330                  28.01
  37                       JFP978               3585277                68                3383                  27.90
  38                       JFP980               3654588                67                3385                  28.00
  39                       JFP981               3580367                68                3388                  27.90
  40                       JFP982               3670557                62                3406                  28.01
  41                       JFP983               3657522                46                3388                  28.00
  42                       JFP986               3669049                58                3406                  27.99
  43                       JFP992               3657868                70                3376                  28.01
  44                       JJC                  3259329                69                2970                  28.12
  45                       JP55                 3347300                1                 3088                  28.38
  46                       JP838                3530414                1                 3244                  28.38
  47                       MJR7757A             3585666                274               3265                  27.79
  48                       NA                   3417203                31                3157                  28.33
  49                       NCTC8239             3324319                55                2942                  28.66
  50                       SM101                2921996                3                 2696                  28.23
  51                       WAL14572             3462156                35                3264                  28.10
  52                       NCTC13170            3310238                1                 2993                  28.36
  53                       NCTC2544             3195093                1                 2854                  28.46
  54                       NCTC8503             3577234                9                 3294                  28.20
  55                       NCTC8678             3005443                6                 2785                  28.12
  56                       NCTC8797             3021559                5                 2813                  28.21
  Summary: Median(range)   3.58(2.92-4.12) Mb   65(1-274)              3304(2696-3896)   28.02(27.79-28.66)    

Pangenome construction and analysis
-----------------------------------

To define key genomic components, we next constructed the pangenome of *C. perfringens* encompassing 56 isolates, which represents the largest analysis of this type to date. This pangenome comprises 11,667 genes; 1470 core genes and 10,197 accessory genes (Figure [2A](#F2){ref-type="fig"}). Remarkably, only 12.6% represented core genes and a surprisingly high 44% (5139/11667) of unique genes (defined as genes only present in 1 strain in this pangenome; Figures [2B--E](#F2){ref-type="fig"}). This analysis implies very high genome plasticity in this pathogen, more than any other known prokaryotes currently published and studied (Mcinerney et al., [@B51]).

![Visualisation and statistics of *C. perfringens* pangenome. **(A)** Core and accessory genes statistics. **(B)** Frequency bar graphs of number of identical genes against number of genomes. **(C)** Number of new genes and unique genes along pangenome computation. **(D)** Number of conserved genes and total genes along pangenome calculation. **(E)** Linearised pangenomic view of 56 *C. perfringens* isolates. Green cells represent syntenies aligned next to Neighbour-Joining core-genome based phylogenetic tree.](fmicb-08-02485-g0002){#F2}

Phylogeny and genome comparison
-------------------------------

A core-genome phylogenetic approach was used for inference of *C. perfringens* genetic relatedness of these 56 isolates (Figure [3](#F3){ref-type="fig"}). The generated phylogenetic tree indicated four main clades, which correlated with pertinent metadata (Table [3](#T3){ref-type="table"}). Food poisoning isolates SM101, NCTC8797, and NCTC8678 (collected between1940--60 from diseased human adults) clustered in a single lineage (clade 1), whereas human, sheep, chicken, dog, horse, and soil isolates intermingled in clade 2 or clade 3, suggesting potential spread and transmission between hosts. In clade 4 (clearly split from clade 1--3), most isolates were collected from a North American dog and horse *C. perfringens* haemorrhagic enteritis study (JFP isolates) indicating these isolates might be host- and disease-specific. This supports previous work where these JFP *netF*-positive isolates were found to cluster closely in a cgMLST tree (Mehdizadeh Gohari et al., [@B54]). Furthermore, the presence of 2 JFP isolates of Swiss origin also clustered in clade 4, which again suggests disease- and host- specificity, but exclusion of geographical linkages. We also observed that different toxinotypes grouped within the same clade (Figure [3](#F3){ref-type="fig"} and Table [3](#T3){ref-type="table"}). These findings are similar to those previously reported by Hassan et al. and Mehdizadeh Gohari et al. and suggest that certain toxin genes are encoded within the accessory genome (Li et al., [@B45]; Hassan et al., [@B29]; Park et al., [@B67]; Mehdizadeh Gohari et al., [@B54]). Our analysis also demonstrates the presence of several major toxins encoded within *C. perfringens* plasmids (sequences individually retrieved from NCBI nucleotide database), highlighting the potential for toxin gene transfer via HGT (Supplementary Figure [1](#SM2){ref-type="supplementary-material"}). Interestingly, whole-genome alignment-free phylogeny (Supplementary Figure [2](#SM2){ref-type="supplementary-material"}) shows the clustering of toxinotypes (B-E in 1 lineage), in contrast to the core-genome based phylogeny (Figure [3](#F3){ref-type="fig"}), which further supports the hypothesis that several specific major toxins obtained via HGT are present in accessory genome.

![Genome comparison and core-genome phylogeny of *C. perfringens*. Core-genome based Neighbour-Joining (NJ) phylogeny of 56 isolates. Branch support values \>70 (based on 1,000 bootstrap replicates) are shown on the nodes. Categories of metadata were displayed for comparison. MJR7757A is assigned to Clade 4 although it is distant from the rest of JFP isolates.](fmicb-08-02485-g0003){#F3}

###### 

Metadata of the *C. perfringens* genomes used for analysis in this study.

       **Isolate**          **Alternative name**     **Toxino-type**   **Year of isolation[^\*^](#TN1){ref-type="table-fn"}**   **Origin of isolates**             **Host diseased states**        **NCBI accession**             **References**
  ---- -------------------- ------------------------ ----------------- -------------------------------------------------------- ---------------------------------- ------------------------------- ------------------------------ ---------------------------------------------------------------------------------
  1    ATCC13124            NCTC8237                 A                 1941                                                     Human                              Gas gangrene                    [SAMN02604008](SAMN02604008)   Möllby et al., [@B55]
  2    SM101                NCTC8798                 A                 1953                                                     Meat rissole/Human                 Food poisoning                  [SAMN02604026](SAMN02604026)   Hobbs et al., [@B32]; Myers et al., [@B57]
  3    Strain 13            Lechien                  A                 1939                                                     Human                              Gas gangrene                    [SAMD00061119](SAMD00061119)   Paquette and Fredette, [@B66]; Mahony and Moore, [@B48]; Shimizu et al., [@B83]
  4    FORC_003             FORC3                    A                 2015                                                     Contaminated food                  n/a                             [SAMN03140316](SAMN03140316)   n/a
  5    JP55                 JFP55                    A                 1999                                                     Foal                               Necrotizing enteritis           [SAMN03372134](SAMN03372134)   Mehdizadeh Gohari et al., [@B53]
  6    JP838                JFP838                   A                 2009                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN03377063](SAMN03377063)   Mehdizadeh Gohari et al., [@B53]
  7    FORC_025             FORC25                   A                 2016                                                     Human                              Food poisoning                  [SAMN04209542](SAMN04209542)   n/a
  8    F262                                          A                 2011                                                     Calf                               Bovine Clostridial abomasitis   [SAMN00199225](SAMN00199225)   Nowell et al., [@B62]
  9    WAL-14572                                     A                 2012                                                     Human (gut of an autistic child)   Human Microbiome Project        [SAMN02463856](SAMN02463856)   Ribeiro et al., [@B74]
  10   CP4                                           A                 2006                                                     Chicken                            Necrotic enteritis              [SAMN04017578](SAMN04017578)   Lepp et al., [@B43]
  11   MJR7757A                                      A                 2016                                                     Human (vagina)                     Human Microbiome Project        [SAMN03842618](SAMN03842618)   Ribeiro et al., [@B74]
  12   JGS1495                                       C                 2007[^\*^](#TN1){ref-type="table-fn"}                    Pig                                Diarrhoea                       [SAMN02436294](SAMN02436294)   Lepp et al., [@B43]
  13   ATCC3626             NCTC13110, NCIMB 10691   B                 1955                                                     Lamb                               Dysentery                       [SAMN02436295](SAMN02436295)   Lepp et al., [@B43]
  14   JGS1987                                       E                 2007[^\*^](#TN1){ref-type="table-fn"}                    Calf                               Haemorrhagic Enteritis          [SAMN02436167](SAMN02436167)   Lepp et al., [@B43]
  15   F4969                                         A                 1995                                                     Human                              Diarrhoea                       [SAMN02436168](SAMN02436168)   Cornillot et al., [@B16]
  16   NCTC8239             ATCC12917                A                 1949                                                     Salt beef/ Human                   Food poisoning                  [SAMN02436239](SAMN02436239)   Hassan et al., [@B29]
  17   JGS1721                                       D                 2008[^\*^](#TN1){ref-type="table-fn"}                    Sheep                              Enterotoxaemia                  [SAMN02436277](SAMN02436277)   Hassan et al., [@B29]
  18   JJC                                           A                 2013                                                     Landfill sludge                    n/a                             [SAMN02317206](SAMN02317206)   Wong et al., [@B97]
  19   2789STDY5608889                               A                 2015[^\*^](#TN1){ref-type="table-fn"}                    Human                              Healthy donor                   [SAMEA3545297](SAMEA3545297)   n/a
  20   JFP718                                        A                 2011                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323879](SAMN05323879)   Mehdizadeh Gohari et al., [@B54]
  21   JFP774                                        A                 2011                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323883](SAMN05323883)   Mehdizadeh Gohari et al., [@B54]
  22   JFP728                                        A                 2011                                                     Foal                               Necrotizing enteritis           [SAMN05323881](SAMN05323881)   Mehdizadeh Gohari et al., [@B54]
  23   JFP727                                        A                 2011                                                     Foal                               Necrotizing enteritis           [SAMN05323880](SAMN05323880)   Mehdizadeh Gohari et al., [@B54]
  24   JFP795                                        A                 2012                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323884](SAMN05323884)   Mehdizadeh Gohari et al., [@B54]
  25   JFP801                                        A                 2002                                                     Foal                               Necrotizing enteritis           [SAMN05323886](SAMN05323886)   Mehdizadeh Gohari et al., [@B54]
  26   JFP804                                        A                 2010                                                     Foal                               Necrotizing enteritis           [SAMN05323887](SAMN05323887)   Mehdizadeh Gohari et al., [@B54]
  27   JFP796                                        A                 2012                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323885](SAMN05323885)   Mehdizadeh Gohari et al., [@B54]
  28   JFP771                                        A                 2011                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323882](SAMN05323882)   Mehdizadeh Gohari et al., [@B54]
  29   JFP810                                        A                 2012                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323888](SAMN05323888)   Mehdizadeh Gohari et al., [@B54]
  30   JFP826                                        A                 2012                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323889](SAMN05323889)   Mehdizadeh Gohari et al., [@B54]
  31   JFP828                                        A                 2011                                                     Foal                               Necrotizing enteritis           [SAMN05323890](SAMN05323890)   Mehdizadeh Gohari et al., [@B54]
  32   JFP829                                        A                 2010                                                     Foal                               Necrotizing enteritis           [SAMN05323891](SAMN05323891)   Mehdizadeh Gohari et al., [@B54]
  33   JFP833                                        A                 2000                                                     Foal                               Necrotizing enteritis           [SAMN05323892](SAMN05323892)   Mehdizadeh Gohari et al., [@B54]
  34   JFP834                                        A                 2002                                                     Foal                               Necrotizing enteritis           [SAMN05323893](SAMN05323893)   Mehdizadeh Gohari et al., [@B54]
  35   JFP836                                        A                 2008                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323894](SAMN05323894)   Mehdizadeh Gohari et al., [@B54]
  36   JFP914                                        A                 2009                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323895](SAMN05323895)   Mehdizadeh Gohari et al., [@B54]
  37   JFP916                                        A                 2009                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323896](SAMN05323896)   Mehdizadeh Gohari et al., [@B54]
  38   JFP921                                        A                 2007                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323897](SAMN05323897)   Mehdizadeh Gohari et al., [@B54]
  39   JFP922                                        A                 2006                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323898](SAMN05323898)   Mehdizadeh Gohari et al., [@B54]
  40   JFP923                                        A                 2006                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323899](SAMN05323899)   Mehdizadeh Gohari et al., [@B54]
  41   JFP941                                        A                 2013                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323900](SAMN05323900)   Mehdizadeh Gohari et al., [@B54]
  42   JFP961                                        A                 2013                                                     Dog                                Haemorrhagic gastroenteritis    [SAMN05323901](SAMN05323901)   Mehdizadeh Gohari et al., [@B54]
  43   JFP978                                        A                 2011                                                     Foal                               Necrotizing enteritis           [SAMN05323902](SAMN05323902)   Mehdizadeh Gohari et al., [@B54]
  44   JFP980                                        A                 2006                                                     Foal                               Necrotizing enteritis           [SAMN05323903](SAMN05323903)   Mehdizadeh Gohari et al., [@B54]
  45   JFP981                                        A                 2004                                                     Foal                               Necrotizing enteritis           [SAMN05323904](SAMN05323904)   Mehdizadeh Gohari et al., [@B54]
  46   JFP982                                        A                 2001                                                     Foal                               Necrotizing enteritis           [SAMN05323905](SAMN05323905)   Mehdizadeh Gohari et al., [@B54]
  47   JFP983                                        A                 2004                                                     Foal                               Necrotizing enteritis           [SAMN05323906](SAMN05323906)   Mehdizadeh Gohari et al., [@B54]
  48   JFP992                                        A                 2008                                                     Foal                               Necrotizing enteritis           [SAMN05323908](SAMN05323908)   Mehdizadeh Gohari et al., [@B54]
  49   JFP986                                        A                 2011                                                     Foal                               Necrotizing enteritis           [SAMN05323907](SAMN05323907)   Mehdizadeh Gohari et al., [@B54]
  50   1207_CPER                                     A                 2012                                                     Human (blood)                      ICU patient                     [SAMN03197169](SAMN03197169)   Roach et al., [@B75]
  51   NA (not available)                            A                 2013                                                     Human/infant                       Premature infant                [SAMN05509317](SAMN05509317)   Raveh-Sadka et al., [@B71]
  52   NCTC8678             ATCC12919                A                 1951                                                     Human                              Food poisoning                  [SAMEA3867459](SAMEA3867459)   Hobbs et al., [@B32]
  53   NCTC8797             HF2985/50                A                 1950                                                     Salt beef                          Food poisoning                  [SAMEA3867461](SAMEA3867461)   Hobbs et al., [@B32]
  54   NCTC13170            DSMZ 100947/ D10         A                 1993                                                     Human                              Food poisoning                  [SAMEA3867463](SAMEA3867463)   Mooijman et al., [@B56]
  55   NCTC8503             CN366                    D                 1930                                                     Chicken                            Necrotic enteritis              [SAMEA3879480](SAMEA3879480)   Bennetts, [@B6]
  56   NCTC2544             STEELE COL 5             A                 1928                                                     Human                              Infected gall bladder           [SAMEA3919787](SAMEA3919787)   n/a

*Year of isolation here is predicted based on sequence submission date on public genome databases due to non-traceability in literature*.

Multi-dimensional scaling (MDS) investigation (Supplementary Figure [3](#SM2){ref-type="supplementary-material"}) based on whole-genome gene-absence-presence phylogeny (Supplementary Figure [4](#SM2){ref-type="supplementary-material"}) also mirrors the core-genome phylogeny findings (Figure [3](#F3){ref-type="fig"}); food-poisoning isolates cluster tightly, JFP isolates nest in 2 distinct lineages (clades 2 and 4) and remaining isolates form another cluster. Using JP838 as our reference genome (as it contains a large 3.5 Mbp chromosome for nucleotide comparison) we generated a circular genome comparison figure, based on 1--3 strains from each of the 4 core-genome clades (Supplementary Figure [5](#SM2){ref-type="supplementary-material"}). This comparison supports our results from the pangenomic analysis highlighting significant variation; faded areas (\<80% sequence similarity) exist in several regions as well as regions (\>10) with differences in GC content, which may indicate genomic island insertion sites via HGT. Interestingly, an additional whole-genome search on strain JP838 indicated that most coding sequences predicted in divergent GC regions encode for hypothetical protein genes (via BLAST NR database) of unknown function.

Functional annotation of core and accessory genomes
---------------------------------------------------

We next analysed both the core and accessory genomes at a functional level using "Clusters of Orthologous Groups of proteins" (COG) and "Evolutionary Genealogy of Genes: Non-supervised Orthologous Groups" (eggNOG) databases (Galperin et al., [@B21]; Huerta-Cepas et al., [@B34]), to probe potential *C. perfringens* host adaption and/or pathogenesis traits (Figure [4](#F4){ref-type="fig"}).

![Functional annotation (COG) of *C. perfringens* core and accessory genomes. **(A)** Core genome functional annotation. **(B)** Accessory genome functional annotation. The smaller-scale grey-background charts show the percentage of gene count of each functional class in both core and accessory genomes corresponding to the functional categories. Non-matching genes (unclassified) are not included in the statistics.](fmicb-08-02485-g0004){#F4}

Interestingly, 849 genes were assigned to protein families associated with "replication, recombination, and repair" comprising mainly transposases (*n* = 254), integrases (*n* = 31), and phage proteins (*n* = 7) within the accessory genome. Whereas, only 79 genes encoded within the core genome were assigned to this functional class, suggesting a key difference between both genomes at a functional level (849 vs. 79; 16.2 vs. 5.6%). Genes associated with "defense mechanisms" were higher within the accessory genome (*n* = 202), when compared to the core genome (*n* = 48), which includes genes encoding efflux pumps, restriction enzymes and ABC transporters (linked with iron uptake systems). Genes involved in metabolism (including carbohydrate, amino acid, and lipid) are proportionately more represented within the core genome (16.8%) vs. the accessory genome (8.3%), whilst recombination and cell-wall biogenesis related genes dominate the functionality of the accessory genome (27.1% vs. core genome: 12.2%). Notably, as indicated above there is a high proportion of unknown-function genes observed in both genomes (core: 24% vs. accessory: 38.7%; Figure [4](#F4){ref-type="fig"}).

*In Silico* profiling of virulence traits
-----------------------------------------

Toxins secreted by *C. perfringens* have long been considered key virulence factors and are implicated in multiple clinical disease phenotypes (Welch and Nuttall, [@B95]; Rood, [@B76]). Primary toxins produced include α-toxin, β-toxin, ι-toxin, and ε-toxins, which are used to classify this pathogen into different toxinotypes (Petit et al., [@B69]). These toxins, as well as additional toxins β2-toxin and perfringolysin O, potentially initiate pathogenesis through pore-forming and cytolysis (Supplementary Table [4](#SM2){ref-type="supplementary-material"}). Therefore, we analysed the toxin profiles of the 56 isolates, and additional virulence-associated factors such as antimicrobial resistance (AMR) and prophage content (Figure [5](#F5){ref-type="fig"}).

![Virulence-associated potentials in *C. perfringens* genomes and plasmids. Heat-map visualising exotoxins, antimicrobial resistance, prophage profiles, and CRISPR counts of 56 *C. perfringens* genomes. Presence of genes are indicated by cell colours: grey (absence); red, blue, and yellow (presence). Purple-labelled isolates indicate historical isolates (pre-antibiotic era).](fmicb-08-02485-g0005){#F5}

Several toxins, including α-toxin (*plc*), α-clostripain (*ccp*), and microbial collagenase (*colA*) genes are conserved in all isolates (Figure [5](#F5){ref-type="fig"}). Other toxins, such as enterotoxin (*cpe*), a food-poisoning-linked toxin, was found to be encoded in food-poisoning isolates SM101 and NCTC8797, however this gene is also present in all JFP isolates (haemorrhagic enteritis isolates). Perfringolysin O (*pfoA* or *pfo*), a well-characterised pore-forming toxin, is encoded in most genomes except food-poisoning and JJC environmental isolates and presence of sialidase genes (*nan* and *nag*) vary across the isolates while *netB, netE, netF*, and *netG* genes were found to be uniquely encoded within JFP isolates (associated with haemorrhagic enteritis in dogs and foals), as reported previously (Mehdizadeh Gohari et al., [@B53]).

Antimicrobial-peptide (AMP) resistance gene multi-peptide resistance factor (*mprF*) was detected in all isolates. This gene is highly-conserved in certain Gram-positive and Gram-negative bacteria (Figure [5](#F5){ref-type="fig"}) and is known to confer resistance through modifying surface molecules of AMPs, including host defensins, and potentially also aminoglycoside antibiotics (Ernst and Peschel, [@B20]; Cole and Nizet, [@B14]). Tetracycline-resistant efflux protein *tetA(P)* gene (Bannam et al., [@B5]) were detected in 75% of the isolates (*n* = 42), and 23% of the isolates (*n* = 14) harboured double *tet*-resistance genes---*tetA(P)* and *tetB(P)*. The only other AMR-associated gene detected was specific aminoglycosides resistance gene (*ANT(6)-Ib*), which was encoded within 1 toxinotype C porcine isolate JGS1495.

Finally, genome scanning for prophage elements indicated that 19 in total were encoded, potentially derived from a variety of bacterial genera including *Aeromonas, Bacillus, Clostridium, Escherichia*, and *Staphylococcus* (Figure [5](#F5){ref-type="fig"}). Notably, JFP isolates also displayed unique prophage profiles including *Clostridium* phage ϕvB_cpes_CP51 (*n* = 48), *Aeromonas* phage ϕphiAS4 (*n* = 47), ϕaes508 and ϕ25 (*n* = 45), and *Clostridium* phage ϕphiS63 (*n* = 44). Interestingly, 40/56 (71.5%) isolates do not encode CRISPR system at all (*in silico* prediction = 0; Figure [5](#F5){ref-type="fig"}).

Discussion {#s3}
==========

Although *C. perfringens* is an important causative agent of animal and human infections; our knowledge on the genome content and phylogenic characteristics of this pathogenic bacterium is currently limited. Our current study, analysing the largest number of *C. perfringens* genomes to date, highlights significant genomic plasticity, and an arsenal of key virulence factors, including toxins and AMR genes, that are encoded by this pathogen.

Using the 16S rRNA gene to initially probe *C. perfringens* phylogenic relationships (Koch et al., [@B39]), we observed clear deviation of 16S alignment from other *Clostridium* species (Figure [1](#F1){ref-type="fig"}), with *C. baratii* and *C. sardiniense* as the closest relatives of *C. perfringens* (16S sequence similarity \~95.3 and 95.1%), which agrees with previous 16S phylogenetic studies (Collins et al., [@B15]; Vos et al., [@B94]). We also performed alignment-free whole-genome-based phylogenetics, which has been reported to represent a more comprehensive and robust method for clustering genetically variable prokaryotes including *Helicobacter pylori* (Van Vliet and Kusters, [@B93]; Bernard et al., [@B7]). Our analysis indicates that this approach can also be used for *C. perfringens*, as we observed near-identical phylogeny when compared to the core-genome based method (Supplementary Figure [2](#SM2){ref-type="supplementary-material"}), and may prove useful in epidemiology and outbreak management.

Previous limited genomic studies have indicated that *C. perfringens* is a genetically diverse organism, and our larger scale study probing 56 genomes also supports this notion. We determined that *C. perfringens* has a highly variable open/infinite pangenome, with new genes potentially being added at an average of 106 genes for each new genome sequenced (Supplementary Figure [6](#SM2){ref-type="supplementary-material"}), which is in comparison to other pathogens, including *Yersinia pestis* (Eppinger et al., [@B19]) and *Bacillus anthracis* (Rouli et al., [@B78]), which have closed pangenomes. The "lifestyle" of the organism is proposed to reflect the nature of the pangenome, and *C. perfringens\'* ability to thrive in multiple host species and environmental niches, including the human and animal gut and soil, allows active interaction with other bacterial species, and links to our open pangenome data (Rouli et al., [@B78]). To our knowledge, only a handful of bacterial pangenome studies have reported extreme pan-genomic variation. This trait (12.5% core genes) is an uncommon observation in other bacteria and is significantly lower than other reported prokaryotic species including *C. difficile* (30.3%) (Knight et al., [@B38]), *Streptococcus pneumoniae* (46.5%) (Hiller et al., [@B31]), *Salmonella enterica* (16%), and *Klebsiella pneumoniae* (26%) (Mcinerney et al., [@B51]). It should be noted that this pangenome analysis may be limited in terms of capturing total *C. perfringens* diversity due to the fact that 30 isolates in our analysis are from a single study (Mehdizadeh Gohari et al., [@B54]). These *netF*-positive isolates were sequenced and assembled for plasmid pathogenicity analysis, and were reported to have tight clonal relationship using a MLST approach that could potentially bias the analysis of this dataset. Thus, we expect that due to *C. perfringens\'* wide host and environmental range, additional genetic variation potentially exists, and that a significantly larger-scale study, encompassing a greater variety and number of isolates from multiple ecological niches, would be required to obtain higher-resolution evolutionary insights.

*C. perfringens* is recognised to be the most prolific toxin-producing organism currently characterised, and is reported to produce \>20 exotoxins. However, not all strains produce all toxins, and certain toxins are encoded on plasmids rather than chromosomes (Supplementary Figure [1](#SM2){ref-type="supplementary-material"}). In our analysis, we showed that individual strains produce a diverse profile of toxins, with the exception of the JFP isolates, which display a unique pattern of toxin gene profiles (netE, netF, and netG), inferring that these encoded toxins may be associated with specific hosts (i.e., dogs and horses), and/or disease (i.e., haemorrhagic enteritis) (Mehdizadeh Gohari et al., [@B53]). Although poultry necrotic enteritis (NE) is thought to be mediated through the *netB* toxin, the NE isolate NCTC8503 was not found to encode this gene, which confirms a previous study by Brady et al. who determined that *netB* (via PCR testing) was present in both healthy and diseased chickens (Brady et al., [@B9]). Interestingly, *netB* was detected in 87.5% JFP isolates (28/32), suggesting that netB toxin might be involved in haemorrhagic enteritis in dogs and horses. Whist our analysis provides interesting linkages with toxin-associated genes with disease and host phenotypes, determination of specific associations will require further WGS data from a wider variety of isolates (including from healthy hosts), and confirmation from experimental studies.

As *C. perfringens* produces this vast array of toxins, a combination of several "key toxins" are traditionally used to type this species. However, our understanding behind the disease-toxinotype link is limited at present, in part due to lack of in-depth WGS studies. We observed that most of the disease-causing isolates in this dataset are toxinotype A (88%; 44/50), and are associated with diverse diseases in different hosts, suggesting the need to review current toxinotyping methods to reflect *C. perfringens* genetic and pathogenesis relationships more closely. From a public health standpoint, a reliable typing method is also necessary to track the spread of bacterial pathogens, and outbreaks. Currently, there is a move from traditional serotyping and MLST approaches to more recent WGS core-genome based methods, which are employed by national-level health department including Public Health England in the UK (Ashton et al., [@B4]). Notably, phylogenomic clustering (using CVTree) resembles the core-genome tree, indicating the possibility of employing phylogenomic approaches for large dataset epidemic analysis, as it uses significantly less computational resources (Bernard et al., [@B7]).

The extreme pan-genomic variation of *C. perfringens*, appears to be driven by HGT events, as indicated by the high number of genes associated with transposases, integrases, and phages, which infers the high potential for gene gain or loss events (Figure [4](#F4){ref-type="fig"}). Notably, *C. perfringens* is found in multiple ecological niches, which are associated with diverse microbial (including viral) communities. Genomic integration of prophages seemingly represents a key source of genetic diversity in *C. perfringens*, and prophage diversity in these isolates surpass the phage contents of *C. difficile*; 7 prophages were found in a total of 44 isolates (Knight et al., [@B38]). Notably, phages in the human gut are reported to outnumber bacteria by at least a factor of 10, and their lysogenic lifestyle has a powerful biological impact on its hosts such as modifying the fitness and metabolism of bacterial hosts (Brüssow and Hendrix, [@B11]). Bacteriophages were reported to boost the sporulation capacity of *C. perfringens* in several studies, which reflects the survival strategy employed by these viral particles (Stewart and Johnson, [@B86]). Some prophage-like genes were also associated with toxin secretion in *C. difficile* (Goh et al., [@B24]), *Salmonella enterica* (Thomson et al., [@B88]), and *E. coli* (Zhang et al., [@B98]). Thus, diverse prophage-associated gene integration in *C. perfringens* genomes may be central for our understanding of the pathogenicity of *C. perfringens* in terms of human and animal health. This high prophage genome plasticity is further supported by our CRISPR (Clustered regularly interspaced short palindromic repeats) array investigation on these 56 isolates as 71.5% (40/56) are predicted to possess no CRISPR system (count = 0), which encodes systems to defend against viral/phage invasion (Figure [5](#F5){ref-type="fig"}). Interestingly, genes involved in "defense mechanisms" are encoded at higher numbers within the accessory genome (*n* = 202), than the core genome (*n* = 48), again suggesting constant genomic adaptation to environmental change. These include genes encoding multidrug efflux pumps (associated with antibiotic resistance; *n* = 11) and ABC transporters (linked with iron-uptake mechanisms and multi-drug resistance; *n* = 83) (Köster, [@B41]; Andersen et al., [@B2]). Notably, genes encoding functions expected to be conserved, such as metabolism (i.e., carbohydrate, amino acid, and lipid metabolism) are more represented within the core (16.8%) rather than the accessory genome (8.3%), indicating their critical functionality in terms of colonisation and growth in different nutritional environments.

There is an ever-increasing incidence of multi-drug resistance pathogens that now pose a critical risk to human and animal health. AMR within *C. perfringens* strains is a serious concern due to its ability to encode multiple virulence associated factors e.g. toxins, that are linked to severe disease. Previous phenotyping-based studies have reported *C. perfringens* as a multidrug resistant pathogen (resist against \>1 antimicrobial drug) (Tansuphasiri et al., [@B87]). However, our genomic analysis indicates that tetracycline resistance genes are the only AMR-specific genes that are wide-spread in this pathogen, which corresponds to previous findings of phenotypically observed tetracycline resistance in *C. perfringens* strains isolated from pigs, human, and environments (Rood et al., [@B77]). Resistance genes *tetA(P)* and *tetB(P)* are both tetracycline efflux proteins most commonly known to be encoded in *C. perfringens* since the 1980s (Lyras and Rood, [@B47]). Notably, our data indicates that strains isolated prior to the 1950s do not encode any *tet* genes, which may correlate with the fact that tetracycline did not come into commercial use until 1978, supporting the emergence of antimicrobial resistance under selective pressure in the post-antibiotic era. Although *C. perfringens* does encode tetracycline resistance-associated genes, this is a limited AMR profile when compared to other Gram-positive enteric pathogens like *C. difficile* (Knight et al., [@B38]). Novel/uncharacterised AMR genes and transmission route (directly from environments such as soil) may account for these findings, however a larger dataset from hospital and/or farming environments and phenotypic testing is required to confirm this hypothesis. Nevertheless, it is suggestive that efflux pumps families including efflux pumps (e.g., *mepA*) and ATP-Binding Cassette (ABC) transporters were *in silico* detected as these could potentially play a significant role in multidrug resistance as observed in previous clinical cases (Andersen et al., [@B2]). Furthermore, the environment in which *C. perfringens* resides (e.g., the gut) could also potentially play a significant role in the acquisition of new AMR genes via the "resistome," and as such warrants further investigations (Browne et al., [@B10]). The host also has specific mechanisms for directly killing gut-associated bacteria including via AMPs. Interestingly, the *mprF* gene (known to be involved in resistance to human defensins) was found to be conserved in all *C. perfringens* genomes, which may link to its ability to evade host-associated defenses for gut colonisation. Indeed, previous studies in *Staphylococcus aureus* have indicated that *mprF* mutant strains are more prone to mammalian AMP killing including neutrophil defensins (Peschel et al., [@B68]), and mutants are less virulent in animal infection models (Kristian et al., [@B42]). Importantly, homologues of *mprF* are also reported to dampen the effectiveness of certain clinical antimicrobials (aminoglycosides) such as vancomycin and gentamicin (Nishi et al., [@B61]), and this may link to previous studies showing resistance of *C. perfringens* to these antibiotics (Traub and Raymond, [@B89]; Tyrrell et al., [@B90]; Osman and Elhariri, [@B64]).

Conclusion {#s4}
==========

High-throughput WGS has paved the way for in-depth pangenomic studies into bacterial species, however previous studies on *C. perfringens* have utilised a maximum of 12 strains for analysis, and thus genomic information on this pathogen is currently limited. Our analysis of 56 strains indicates a surprisingly diverse pangenome, and *in silico* functional analysis reveals frequent exchange of genes in its evolutionary history, associated with prophages, toxins and AMR genes, that potentially influence pathogenicity. Interestingly, this study did not correlate any toxinotype to a specific disease in phylogenetic clustering, however a larger dataset may be needed to establish any causative relationships. As most of the isolates in our study are from diseased patients/animals, inclusion of isolates from healthy samples may enable us to understand the genomic signatures that separate commensal from pathogenic *C. perfringens* (Nagpal et al., [@B59]). Whilst these genomic studies are of central importance it is vital to also determine the phenotypic disease-causing mechanisms, thus experimental studies are essential to probe our understanding of *C. perfringens* pathogenesis in tandem with *in silico* exploration.

Materials and methods {#s5}
=====================

Bacterial isolates and metadata
-------------------------------

*C. perfringens* isolates previously sequenced and deposited in NCBI were used in this study (*n* = 51; retrieved in March 2017), a further 5 *C. perfringens* isolates (NCTC8678, NCTC8797, NCTC13170, NCTC2544, and NCTC8503) were sequenced as part of the NCTC 3000 sequencing project to be included in this study. Metadata of all 56 isolates were retrieved manually online (March 2017) either from published literature, National Center of Biological Information (NCBI) databases or European Bioinformatics Institute (EBI) databases. Year of isolation and geographical origins of isolates were taken from published research papers, otherwise estimated using dates/locations on public databases as indicated. WGS accessions, references and metadata for all genomes are provided in the Table [3](#T3){ref-type="table"}.

Genomic DNA extraction and whole genome sequencing
--------------------------------------------------

For genomic DNA extraction, *C. perfringens* strains (NCTC8678, NCTC8797, NCTC13170, NCTC2544, and NCTC8503) were propagated on blood agar at 37°C for 36 h under anaerobic conditions. Bacterial lysates were prepared in buffer B1 (containing additional RNase A, protease, and Lysozyme) and the lysates were incubated at 80°C for 24 h. Post-incubation high Molecular weight DNA was isolated from *C. perfringens* strains using the Qiagen midi kit. DNA quality (\>60 kb) and quantity (\>3 μg) was assessed using the Agilent 2200 TapeStation and Qubit® dsDNA BR Assay Kit respectively. WGS was performed using the PacBio SMRT® DNA Sequencing technology. Appropriate biosafety procedures were in place for both bacterial culturing and DNA extraction.

*De Novo* assembly and annotation
---------------------------------

Assembled genomes (51) previously sequenced were retrieved online on NCBI Genomes database (Geer et al., [@B22]). All 56 genomes were annotated using Prokka v1.10 (Seemann, [@B82]). HGAP.3 from SMRTpipe-2.3.0 was used to perform *de novo* assembly of the 5 strains of *C. perfringens* sequenced on PacBio RS I obtained from ENA, with one SMRT cell per strain assembled into unitigs. The minlongreadlength (assembly seed length) parameter was set such that there was 30X genome coverage above the seed length. Two strains (NCTC13170 and NCTC2544) were assembled into one single unitig of 3,310,238 bp and the rest three strains (NCTC8678, NCTC8503, and NCTC8797) were assembled into 5--9 unitigs with an N50 of over 2,969,557 bp. These assemblies were run on a High-Performance Computing Cluster using SLURM, utilizing 50 Gb of memory and running parallel on four computing nodes taking \~634.93 min to finish.

Pangenome assembly and visualisation
------------------------------------

The annotation files (general feature format, GFF) of 56 *C. perfringens* genomes were submitted to Roary pangenome pipeline v3.6.1 to perform pangenomic analysis (Page et al., [@B65]). Roary was run with default parameters. A gene-absence-presence data matrix was subsequently derived and visualised in Phandango genome visualizer (v0.87) (Hadfield and Harris, [@B27]). Fripan[^2^](#fn0002){ref-type="fn"} was used to visualised MDS clustering of isolates (Supplementary Figure [3](#SM2){ref-type="supplementary-material"}) and gene-presence-absence tree (Supplementary Figure [4](#SM2){ref-type="supplementary-material"}). Recommended R scripts from Roary package were used to generate pangenome stats using R studio(R Development Core Team, [@B72]; Rstudio Team, [@B79]).

Core-genome alignment and construction of phylogenetic trees
------------------------------------------------------------

Core-genome alignment generated using MAFFT v7.305b (Katoh and Standley, [@B36]) was used as input for Seaview v4.0 (Gouy et al., [@B25]) to construct core-genome phylogeny. Neighbour-Joining tree (NJ) was built using Jukes-Cantor model of DNA evolution on a set of 1,000 bootstrap replicates; Maximum-Likelihood (ML) tree was constructed using PhyML v3.0 (Guindon et al., [@B26]), GTR model and supported by Approximate Likelihood Ratio Test (aLRT). Interactive Tree of Life (iTOL) was used as a tree editor to assign clade and annotate metadata (Letunic and Bork, [@B44]).

Alignment-free whole-genome phylogeny
-------------------------------------

CVTree standalone v5.0 was used for constructing alignment-free whole-genome phylogeny with parameters *k* = 6 on amino acid sequences as recommended for prokaryotes and ATCC13124 was selected as the reference sequence (Qi et al., [@B70]). All genomes were subject to Prokka annotation prior to building phylogeny to obtain annotated FASTA files (genes in amino acid sequences) (Seemann, [@B82]). Webtool iTOL was used for phylogeny annotation and editing (Letunic and Bork, [@B44]).

16S rRNA gene alignment, phylogeny, and pair-wise blast
-------------------------------------------------------

This study employs BAsic Rapid Ribosomal RNA Predictor (Barrnap) v0.5 as 16S rRNA gene predictor (Seemann, [@B81]). In-house Perl scripts were utilised for extracting the maximum-length 16S rRNA sequence on the positive strands predicted by Barrnap on the WGS data in each isolate for optimal consistency and comparison (Supplementary Table [1](#SM2){ref-type="supplementary-material"}). Sequence were aligned using MUSCLE v3.8.31 (Edgar, [@B18]). Phylogenetic trees were generated as described in previous section. *Clostridium* species 16S rRNA gene sequences were retrieved from NCBI databases (Supplementary Table [3](#SM2){ref-type="supplementary-material"}). Pair-wise BLASTn was performed using BLAST+ v2.2.30 and in-house Perl scripts (Camacho et al., [@B12]).

Functional annotation of genomes (COG)
--------------------------------------

Core and accessory genes were extracted using in-house Perl scripts based on pangenome data. The Clusters of Orthologous Groups (COG) classification was done on both the extracted datasets using eggnog-mapper (v0.99.3) based on COG and EggNOG databases, and HMMER was used for sequence homology search and COG class assignment on default parameters (Huerta-Cepas et al., [@B34], [@B33]). COG classes assigned to each gene were then extracted using Shell script[^3^](#fn0003){ref-type="fn"} and were plotted using GraphPad Prism v5.04. In-house bash scripts and Linux commands were used to explore annotated data on different functional classes.

*In Silico* analysis of virulence potentials
--------------------------------------------

**Exotoxin profiles**: 23 presently identified toxins and virulent enzymes sequence data from NCBI database were built into database for BLAST query (Supplementary Table [4](#SM2){ref-type="supplementary-material"}). BLAST+ v2.2.30 was employed for sequence similarity search (BLASTn) using in-house Perl and bash scripts (Camacho et al., [@B12]). Heat maps were generated using R heatmap2 package (R Development Core Team, [@B72]). Individual *C. perfringens* plasmids were retrieved from NCBI database for toxin profiling (Supplementary Table [5](#SM2){ref-type="supplementary-material"}). **Antimicrobial resistance**: sequence similarity search was performed as described above using Comprehensive Antimicrobial Resistance Database (CARD) (Jia et al., [@B35]). **Prophage profiles**: sequence similarity search was performed as described above using viral databases retrieved from NCBI (March 2017). Percentage identity of 90% was applied for secondary BLASTn filter. **BLAST parameters**: Double-filter parameters were implemented for screening---expect value of 1e-10 and percentage identity of \>80% for sequence homology inference unless otherwise indicated.

CRISPR array detection
----------------------

CRISPR were predicted using MinCED v0.1.6, a tool derived from CRT (Bland et al., [@B8]; Angly and Skennerton, [@B3]). Default parameters were implemented as follows: minimum number of repeats a CRISPR must contain--3, minimum length of CRISPR repeats--23, maximum CRISPR spacers--26, maximum length of CRISPR spaces--50. Counts were parsed in custom bash scripts and visualised using GraphPad Prism v5.04.

Multiple circular genome comparison
-----------------------------------

Circular whole genome comparisons were generated and visualised using BLAST Ring Image Generator (BRIG) v0.95 (Alikhan et al., [@B1]). Percentage identity cut-offs were indicated in the graph legends.
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